Literature DB >> 26316117

Downregulation of miR-138 as a Contributing Mechanism to Lcn-2 Overexpression in Colorectal Cancer with Liver Metastasis.

Ion Cristóbal1, Blanca Torrejón2, Paula González-Alonso3, Rebeca Manso3, Federico Rojo3, Jesús García-Foncillas4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26316117     DOI: 10.1007/s00268-015-3241-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  5 in total

1.  Up-regulation of neutrophil gelatinase-associated lipocalin in colorectal cancer predicts poor patient survival.

Authors:  Herbert Thomas Maier; Felix Aigner; Birgit Trenkwalder; Matthias Zitt; Natalie Vallant; Alexander Perathoner; Christian Margreiter; Patrizia Moser; Johann Pratschke; Albert Amberger
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

2.  NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models.

Authors:  Yan Sun; Kenji Yokoi; Hui Li; Jun Gao; Limei Hu; Ben Liu; Kexin Chen; Stanley R Hamilton; Dominic Fan; Baocun Sun; Wei Zhang
Journal:  Clin Cancer Res       Date:  2011-05-27       Impact factor: 12.531

3.  Prognostic value of serum neutrophil gelatinase-associated lipocalin in metastatic and nonmetastatic colorectal cancer.

Authors:  Josep Martí; Josep Fuster; Anna M Solà; Georgina Hotter; Rafael Molina; Amalia Pelegrina; Joana Ferrer; Ramon Deulofeu; Constantino Fondevila; Juan Carlos García-Valdecasas
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

4.  Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2.

Authors:  Limin Long; Guoqing Huang; Hongyi Zhu; Yonghong Guo; Youshuo Liu; Jirong Huo
Journal:  J Transl Med       Date:  2013-10-30       Impact factor: 5.531

5.  MicroRNA-138 suppresses neutrophil gelatinase-associated lipocalin expression and inhibits tumorigenicity.

Authors:  Ying Chu Lee; Woan-Fang Tzeng; Tzeon-Jye Chiou; Sin Tak Chu
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

  5 in total
  8 in total

1.  Upregulation of Neutrophil Gelatinase-Associated Lipocalin in Colorectal Cancer Predicts Poor Patient Survival: Reply.

Authors:  Herbert Maier; Felix Aigner
Journal:  World J Surg       Date:  2016-04       Impact factor: 3.352

Review 2.  Implication and role of neutrophil gelatinase-associated lipocalin in cancer: lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer types.

Authors:  Sina Rahimi; Amaneh Mohammadi Roushandeh; Ebrahim Ahmadzadeh; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Mol Biol Rep       Date:  2020-01-22       Impact factor: 2.316

3.  MicroRNA-138 suppresses cell proliferation and invasion of renal cell carcinoma by directly targeting SOX9.

Authors:  Bo Hu; Jianbo Wang; Xunbo Jin
Journal:  Oncol Lett       Date:  2017-10-10       Impact factor: 2.967

Review 4.  Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer.

Authors:  Wubin Zheng; Fan Wu; Kai Fu; Guangshun Sun; Guoqiang Sun; Xiao Li; Wei Jiang; Hongyong Cao; Hanjin Wang; Weiwei Tang
Journal:  Onco Targets Ther       Date:  2021-05-06       Impact factor: 4.147

5.  Exosomes derived from microRNA-138-5p-overexpressing bone marrow-derived mesenchymal stem cells confer neuroprotection to astrocytes following ischemic stroke via inhibition of LCN2.

Authors:  Yiming Deng; Duanduan Chen; Feng Gao; Hong Lv; Guojun Zhang; Xuan Sun; Lian Liu; Dapeng Mo; Ning Ma; Ligang Song; Xiaochuan Huo; Tianyi Yan; Jingbo Zhang; Zhongrong Miao
Journal:  J Biol Eng       Date:  2019-08-28       Impact factor: 4.355

Review 6.  Epigenetic Regulation by lncRNAs: An Overview Focused on UCA1 in Colorectal Cancer.

Authors:  Bernadette Neve; Nicolas Jonckheere; Audrey Vincent; Isabelle Van Seuningen
Journal:  Cancers (Basel)       Date:  2018-11-14       Impact factor: 6.639

7.  Low expression of miR-138 inhibit the proliferation, migration and invasion of colorectal cancer and affect patient survival by targeting SIRT1.

Authors:  Xianwu Kang; Bin Kong; Qiang Chen; Shipeng Zhao
Journal:  Transl Cancer Res       Date:  2021-07       Impact factor: 1.241

8.  miR-138 suppresses cell proliferation and invasion by inhibiting SOX9 in hepatocellular carcinoma.

Authors:  Yahui Liu; Wei Zhang; Kai Liu; Songyang Liu; Bai Ji; Yingchao Wang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.